Overview
Status
Active
Registry date
2015-09-01
Share capital
5,000.00 PLN
Registered address
ul. Komornicka 42F/2, 62-070 Dąbrówka, Poland
Email
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 138 days for 2020).
- 202509/07/2026
- 202413/06/2025
- 202303/07/2024
- 202213/06/2023
- 202123/11/2022
- 202002/03/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Agnieszka Piechocka – President of the Management Board
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Piechockaage 50 | 91 | $1,229.07 | 91% |
Others | 9 | $121.56 | 9% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakład Genetyki Sądowejsp. z o.o. | $727,654.12 | dna-zgs.pl | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
The main business activity of Kahle focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on September 1, 2015.
The headquarters is located at: ul. Komornicka 42F, 62-070 Dąbrówka.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-24
